Irma Airoldi
Overview
Explore the profile of Irma Airoldi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marimpietri D, Corrias M, Tripodi G, Gramignoli R, Airoldi I, Morandi F
Front Immunol
. 2024 Nov;
15:1469771.
PMID: 39512342
Introduction: Extracellular vesicles (EVs) can be released by any cell and are crucial for cell-to-cell communications. EVs have been characterized in patients with solid and hematological tumors, where they play...
2.
Microbes identified from monitoring cell manipulations in 5-year life of the Cell Factory G. Gaslini
Morandi F, Della Lastra M, Bandettini R, Tripodi G, Zara F, Airoldi I
Regen Ther
. 2024 Apr;
27:234-243.
PMID: 38586872
Introduction: Quality and safety of a cell product, essential to guarantee the health of patients, depends on many factors including an appropriate environmental monitoring of the manufacturing rooms. Nonetheless, the...
3.
Morandi F, Della Lastra M, Zara F, Airoldi I
Curr Res Transl Med
. 2024 Mar;
72(4):103445.
PMID: 38493557
The use of γδ T lymphocytes as advanced therapeutic medicinal product has attracted much interest in the last years. Indeed, such cells are an ideal tool for the reconstitution of...
4.
Morandi F, Airoldi I
Int J Mol Sci
. 2022 Mar;
23(6).
PMID: 35328349
HLA-G is an HLA-class Ib molecule that is involved in the establishment of tolerance at the maternal/fetal interface during pregnancy. The expression of HLA-G is highly restricted in adults, but...
5.
Marimpietri D, Airoldi I, Faini A, Malavasi F, Morandi F
Int J Mol Sci
. 2021 Apr;
22(8).
PMID: 33921337
The long-underestimated role of extracellular vesicles in cancer is now reconsidered worldwide by basic and clinical scientists, who recently highlighted novel and crucial activities of these moieties. Extracellular vesicles are...
6.
Cocco C, Morandi F, Airoldi I
Cells
. 2021 Apr;
10(4).
PMID: 33920505
The tumor microenvironment (TME) represents a complex network between tumor cells and a variety of components including immune, stromal and vascular endothelial cells as well as the extracellular matrix. A...
7.
Morandi F, Sabatini F, Podesta M, Airoldi I
Vaccines (Basel)
. 2021 Jan;
9(1).
PMID: 33450862
Neuroblastoma is the most common extracranial pediatric solid tumor with a heterogeneous clinical course, ranging from spontaneous regression to metastatic disease and death, irrespective of intensive chemotherapeutic regimen. On the...
8.
Morandi F, Yazdanifar M, Cocco C, Bertaina A, Airoldi I
Cells
. 2020 Jul;
9(8).
PMID: 32707982
Most studies on genetic engineering technologies for cancer immunotherapy based on allogeneic donors have focused on adaptive immunity. However, the main limitation of such approaches is that they can lead...
9.
Marchica V, Franceschi V, Vescovini R, Storti P, Vicario E, Toscani D, et al.
J Hematol Oncol
. 2020 Jul;
13(1):89.
PMID: 32653014
Background: The oncolytic viruses have shown promising results for the treatment of multiple myeloma. However, the use of human viruses is limited by the patients' antiviral immune response. In this...
10.
Merli P, Algeri M, Galaverna F, Milano G, Bertaina V, Biagini S, et al.
Front Immunol
. 2020 Jun;
11:699.
PMID: 32477328
TcRαβ/CD19-cell depleted HLA-haploidentical hematopoietic stem cell transplantation (haplo-HSCT) represents a promising new platform for children affected by acute leukemia in need of an allograft and lacking a matched donor, disease...